Largecap, Midcap, Smallcap Stocks to Buy After Budget 2025: Dalal Street has staged a series of wild swings since the finance minister delivered and her 8th Budget in a row, with a muted ending to a volatile session on February 1 and mixed moves since. Many investors are once again on the lookout for fresh stock ideas to rebalance their portfolios to reflect the changes necessitated by Budget announcements.
Are you one of them?
Here are a few stocks that analysts have on their 'buy' lists after the Budget presentation.
All images are representational. Image source: PTI, Pexels, AI
1/10Axis Direct has a 'buy' rating assigned to Karnataka Bank shares with a target price of Rs 255.
As of February 3, the target implies a potential upside of 46 per cent in the stock.
2/10KRChoksey has a 'buy' call on UPL shares with a target price of Rs 736 apiece.
4/10BOB Capital Markets has a 'buy' rating assigned to Sun Pharma shares with a target of Rs 2,086 apiece.
5/10HDFC Securities has kept a 'buy' call on the Neogen Chemicals stock with a target of Rs 2,523 per share.
6/10Nuvama has a 'buy' call on SRF shares with a target price of Rs 3,000.
7/10BOB Capital Markets has a 'buy' call on Bandhan Bank shares with a target price of Rs 187.
8/10Sharekhan has a 'buy' rating assigned to Jyothy Labs shares with a target price of Rs 490.
9/10HDFC Securities has a 'buy' rating on Medplus Health Services shares with a target of Rs 900.
10/10HDFC Securities has a 'buy' call assigned to Mahindra Lifespaces with a target of Rs 700 per share.